SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform. FDA clearance came just days after the company inked a partnership with Mayo Clinic to develop precision medicine solutions. The TumorSight platform takes a patient’s standard-of-care imaging to build a custom 3D model of their tumor. The tool provides […]
SimBioSys
SimBioSys, Mayo Clinic partner on AI-powered tech for breast cancer patients
SimBioSys announced today that it entered into a strategic collaboration with Mayo Clinic to develop digital precision medicine solutions. The collaboration aims to develop cloud-based clinical software to support end-to-end decision-making for early-stage breast cancer patients. This includes individualized surgical planning, treatment, drug selection and risk stratification. As part of the collaboration, SimBioSys has had […]
